CRP and melanoma: The four serum biomarker signature consisting of TNF-RII, TGF-α, TIMP-1, and CRP as measured at baseline is significantly prognostic of worse survival in high risk melanoma patients and warrants further investigation as a marker of poor prognosis that my guide patient follow up and the design of future adjuvant studies.